Review



rabbit anti il20rb antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Proteintech rabbit anti il20rb antibody
    Fig. 3 <t>IL20RB</t> promotes stemness and chemoresistance in pancreatic cancer in vivo. A–B Tumor formation results after subcutaneous injection of 105, 106 and 107 PANC-1, respectively, into nude mice. C Tumor growth curve (n = 5 per group). D Statistical analysis of tumor weight at the end of the trial (n = 5 per group). E–F Representative immunohistochemical (IHC) images of NANOG and SOX2 in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm. G Western blot analysis of NANOG, SOX2 and IL20RB in tumor tissues. (H) 10^7 PANC-1 was injected subcutaneously into nude mice, and then gemcitabine 100 mg/kg was intraperitoneally injected twice a week for 4 weeks. I Statistical analysis of tumor weight at the endpoint. J Tumor growth curve. K–L Representative IHC images of pan-CK in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm
    Rabbit Anti Il20rb Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti il20rb antibody/product/Proteintech
    Average 91 stars, based on 3 article reviews
    rabbit anti il20rb antibody - by Bioz Stars, 2026-03
    91/100 stars

    Images

    1) Product Images from "IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer."

    Article Title: IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.

    Journal: Journal of translational medicine

    doi: 10.1186/s12967-023-04800-5

    Fig. 3 IL20RB promotes stemness and chemoresistance in pancreatic cancer in vivo. A–B Tumor formation results after subcutaneous injection of 105, 106 and 107 PANC-1, respectively, into nude mice. C Tumor growth curve (n = 5 per group). D Statistical analysis of tumor weight at the end of the trial (n = 5 per group). E–F Representative immunohistochemical (IHC) images of NANOG and SOX2 in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm. G Western blot analysis of NANOG, SOX2 and IL20RB in tumor tissues. (H) 10^7 PANC-1 was injected subcutaneously into nude mice, and then gemcitabine 100 mg/kg was intraperitoneally injected twice a week for 4 weeks. I Statistical analysis of tumor weight at the endpoint. J Tumor growth curve. K–L Representative IHC images of pan-CK in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm
    Figure Legend Snippet: Fig. 3 IL20RB promotes stemness and chemoresistance in pancreatic cancer in vivo. A–B Tumor formation results after subcutaneous injection of 105, 106 and 107 PANC-1, respectively, into nude mice. C Tumor growth curve (n = 5 per group). D Statistical analysis of tumor weight at the end of the trial (n = 5 per group). E–F Representative immunohistochemical (IHC) images of NANOG and SOX2 in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm. G Western blot analysis of NANOG, SOX2 and IL20RB in tumor tissues. (H) 10^7 PANC-1 was injected subcutaneously into nude mice, and then gemcitabine 100 mg/kg was intraperitoneally injected twice a week for 4 weeks. I Statistical analysis of tumor weight at the endpoint. J Tumor growth curve. K–L Representative IHC images of pan-CK in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm

    Techniques Used: In Vivo, Injection, Immunohistochemical staining, Western Blot

    Fig. 4 IL20RB activates STAT3 phosphorylation to promote pancreatic cancer stemness and chemotherapy resistance. A Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) proteins in pancreatic cancer cell line MIA PaCa-2. B Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) in pancreatic cancer cell line PANC-1. C Real-time quantitative PCR analysis of the mRNA expression of IL20RB, NANOG, SOX2 and POU5F1 in MIA PaCa-2 treated with the vehicle or STAT3 inhibitor (Stattic), respectively (n = 3 in each group). (D) Western blot analysis of IL20RB, STAT3, p-STAT3 (Tyr705), NANOG and SOX2 proteins in MIA PaCa-2 after the vehicle or Stattic treatment. E Sphere-forming assay and statistical analysis of MIA PaCa-2 after treatment with the vehicle or Stattic (n = 3 per group). F Colony formation assay and statistical analysis of MIA PaCa-2 treated with 10 nM gemcitabine for 24 h with or without Stattic (n = 3 per group). G Representative immunofluorescence images of IL20RB, pan-CK and p-STAT3 in human pancreatic cancer tissue sections, scale bar = 40 µm
    Figure Legend Snippet: Fig. 4 IL20RB activates STAT3 phosphorylation to promote pancreatic cancer stemness and chemotherapy resistance. A Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) proteins in pancreatic cancer cell line MIA PaCa-2. B Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) in pancreatic cancer cell line PANC-1. C Real-time quantitative PCR analysis of the mRNA expression of IL20RB, NANOG, SOX2 and POU5F1 in MIA PaCa-2 treated with the vehicle or STAT3 inhibitor (Stattic), respectively (n = 3 in each group). (D) Western blot analysis of IL20RB, STAT3, p-STAT3 (Tyr705), NANOG and SOX2 proteins in MIA PaCa-2 after the vehicle or Stattic treatment. E Sphere-forming assay and statistical analysis of MIA PaCa-2 after treatment with the vehicle or Stattic (n = 3 per group). F Colony formation assay and statistical analysis of MIA PaCa-2 treated with 10 nM gemcitabine for 24 h with or without Stattic (n = 3 per group). G Representative immunofluorescence images of IL20RB, pan-CK and p-STAT3 in human pancreatic cancer tissue sections, scale bar = 40 µm

    Techniques Used: Phospho-proteomics, Western Blot, Real-time Polymerase Chain Reaction, Expressing, Colony Assay, Immunofluorescence



    Similar Products

    rabbit anti il20rb antibody  (Proteintech)
    91
    Proteintech rabbit anti il20rb antibody
    Fig. 3 <t>IL20RB</t> promotes stemness and chemoresistance in pancreatic cancer in vivo. A–B Tumor formation results after subcutaneous injection of 105, 106 and 107 PANC-1, respectively, into nude mice. C Tumor growth curve (n = 5 per group). D Statistical analysis of tumor weight at the end of the trial (n = 5 per group). E–F Representative immunohistochemical (IHC) images of NANOG and SOX2 in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm. G Western blot analysis of NANOG, SOX2 and IL20RB in tumor tissues. (H) 10^7 PANC-1 was injected subcutaneously into nude mice, and then gemcitabine 100 mg/kg was intraperitoneally injected twice a week for 4 weeks. I Statistical analysis of tumor weight at the endpoint. J Tumor growth curve. K–L Representative IHC images of pan-CK in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm
    Rabbit Anti Il20rb Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti il20rb antibody/product/Proteintech
    Average 91 stars, based on 1 article reviews
    rabbit anti il20rb antibody - by Bioz Stars, 2026-03
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 3 IL20RB promotes stemness and chemoresistance in pancreatic cancer in vivo. A–B Tumor formation results after subcutaneous injection of 105, 106 and 107 PANC-1, respectively, into nude mice. C Tumor growth curve (n = 5 per group). D Statistical analysis of tumor weight at the end of the trial (n = 5 per group). E–F Representative immunohistochemical (IHC) images of NANOG and SOX2 in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm. G Western blot analysis of NANOG, SOX2 and IL20RB in tumor tissues. (H) 10^7 PANC-1 was injected subcutaneously into nude mice, and then gemcitabine 100 mg/kg was intraperitoneally injected twice a week for 4 weeks. I Statistical analysis of tumor weight at the endpoint. J Tumor growth curve. K–L Representative IHC images of pan-CK in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm

    Journal: Journal of translational medicine

    Article Title: IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.

    doi: 10.1186/s12967-023-04800-5

    Figure Lengend Snippet: Fig. 3 IL20RB promotes stemness and chemoresistance in pancreatic cancer in vivo. A–B Tumor formation results after subcutaneous injection of 105, 106 and 107 PANC-1, respectively, into nude mice. C Tumor growth curve (n = 5 per group). D Statistical analysis of tumor weight at the end of the trial (n = 5 per group). E–F Representative immunohistochemical (IHC) images of NANOG and SOX2 in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm. G Western blot analysis of NANOG, SOX2 and IL20RB in tumor tissues. (H) 10^7 PANC-1 was injected subcutaneously into nude mice, and then gemcitabine 100 mg/kg was intraperitoneally injected twice a week for 4 weeks. I Statistical analysis of tumor weight at the endpoint. J Tumor growth curve. K–L Representative IHC images of pan-CK in tumor tissue sections and statistical analysis of IHC scores, scale bar = 40 µm

    Article Snippet: Antibodies: rabbit anti-IL20RB antibody (dil. 1:50, Proteintech, 20,521-1-AP); rabbit anti-NANOG antibody (dil. 1:500, Proteintech, 14,295-1-AP); rabbit anti-SOX2 antibody (dil. 1:150, Proteintech, 11,064-1- AP); rabbit phospho-Stat3 (Tyr705) antibody (dil. 1:300, Cell Signaling Technology, 9145); mouse anti-pan-CK antibody (dil. 1:500, Abcam, ab215838); rabbit anti-IL-19 antibody (dil. 1:500, Bioss, bs-10087R) (dil., dilution).

    Techniques: In Vivo, Injection, Immunohistochemical staining, Western Blot

    Fig. 4 IL20RB activates STAT3 phosphorylation to promote pancreatic cancer stemness and chemotherapy resistance. A Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) proteins in pancreatic cancer cell line MIA PaCa-2. B Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) in pancreatic cancer cell line PANC-1. C Real-time quantitative PCR analysis of the mRNA expression of IL20RB, NANOG, SOX2 and POU5F1 in MIA PaCa-2 treated with the vehicle or STAT3 inhibitor (Stattic), respectively (n = 3 in each group). (D) Western blot analysis of IL20RB, STAT3, p-STAT3 (Tyr705), NANOG and SOX2 proteins in MIA PaCa-2 after the vehicle or Stattic treatment. E Sphere-forming assay and statistical analysis of MIA PaCa-2 after treatment with the vehicle or Stattic (n = 3 per group). F Colony formation assay and statistical analysis of MIA PaCa-2 treated with 10 nM gemcitabine for 24 h with or without Stattic (n = 3 per group). G Representative immunofluorescence images of IL20RB, pan-CK and p-STAT3 in human pancreatic cancer tissue sections, scale bar = 40 µm

    Journal: Journal of translational medicine

    Article Title: IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.

    doi: 10.1186/s12967-023-04800-5

    Figure Lengend Snippet: Fig. 4 IL20RB activates STAT3 phosphorylation to promote pancreatic cancer stemness and chemotherapy resistance. A Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) proteins in pancreatic cancer cell line MIA PaCa-2. B Western blot analysis of IL20RB, STAT3 and p-STAT3 (Tyr705) in pancreatic cancer cell line PANC-1. C Real-time quantitative PCR analysis of the mRNA expression of IL20RB, NANOG, SOX2 and POU5F1 in MIA PaCa-2 treated with the vehicle or STAT3 inhibitor (Stattic), respectively (n = 3 in each group). (D) Western blot analysis of IL20RB, STAT3, p-STAT3 (Tyr705), NANOG and SOX2 proteins in MIA PaCa-2 after the vehicle or Stattic treatment. E Sphere-forming assay and statistical analysis of MIA PaCa-2 after treatment with the vehicle or Stattic (n = 3 per group). F Colony formation assay and statistical analysis of MIA PaCa-2 treated with 10 nM gemcitabine for 24 h with or without Stattic (n = 3 per group). G Representative immunofluorescence images of IL20RB, pan-CK and p-STAT3 in human pancreatic cancer tissue sections, scale bar = 40 µm

    Article Snippet: Antibodies: rabbit anti-IL20RB antibody (dil. 1:50, Proteintech, 20,521-1-AP); rabbit anti-NANOG antibody (dil. 1:500, Proteintech, 14,295-1-AP); rabbit anti-SOX2 antibody (dil. 1:150, Proteintech, 11,064-1- AP); rabbit phospho-Stat3 (Tyr705) antibody (dil. 1:300, Cell Signaling Technology, 9145); mouse anti-pan-CK antibody (dil. 1:500, Abcam, ab215838); rabbit anti-IL-19 antibody (dil. 1:500, Bioss, bs-10087R) (dil., dilution).

    Techniques: Phospho-proteomics, Western Blot, Real-time Polymerase Chain Reaction, Expressing, Colony Assay, Immunofluorescence